隐形的负担 - - 未经治疗的肝细胞癌的挑战
1Gastroenterology and Hepatology, Hospital Universitario Ramón y Cajal.
Revista espanola de enfermedades digestivas
|July 30, 2025
概括
这篇社论针对的是肝细胞癌 (HCC) 患者,他们无法接受积极治疗,重点是息治疗. 它强调症状管理和高级肝病和复杂健康需求的人的生活质量.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
背景情况:
- 许多肝细胞癌 (HCC) 患者由于虚弱,并发症或疾病阶段,不适合治疗或活跃癌症治疗.
- 尽管在早期诊断方面取得了进展,但这些患者中很大一部分仅接受以舒适为导向的护理.
- 预后受到肝衰竭严重程度,整体健康状况,瘤特征和患者特定因素的影响.
研究的目的:
- 探索不适合积极治疗的HCC患者的护理需求和结果.
- 倡导一种缓和护理模式,优先考虑症状缓解和生活质量.
- 呼吁包容性研究和针对这一患者群体的医疗保健策略.
主要方法:
- 审查目前的临床方法和预后因素的高级HCC.
- 讨论息干预在治疗症状和改善患者福祉方面的作用.
- 在治疗途径中分析社会背景和患者决策.
主要成果:
- 预后受到肝衰竭,并发症,瘤负担和血管侵袭的显著影响.
- 瘤标志物和社会因素也在生存前景中起作用.
- 患者的偏好和社会背景影响护理决策和结果.
结论:
- 对于没有接受积极治疗的HCC患者来说,转向息护理至关重要.
- 护理应专注于缓解症状,尊重患者的自主权,提高生活质量.
- 未来的研究和医疗保健战略必须具有包容性和同情心,应对这些患者的独特需求.
相关概念视频
Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Hepatitis
99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Cirrhosis I: Introduction
32
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
32
Cirrhosis II: Pathophysiology
53
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
53
Jaundice
48
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
48


